Skip to main content

Disseminated nocardiosis in a patient with alcoholic liver cirrhosis: a case report

Abstract

Background

Nocardia are Gram-positive, aerobic, filamentous bacteria that can cause localized or disseminated infections. Immunocompromised patients are at a higher risk of developing Nocardia infection and further dissemination of the disease. To date, limited data have documented the relationship between nocardiosis and alcoholic liver disease.

Case presentation

We report the case of a 47-year-old man with a known history of alcoholic liver cirrhosis. The patient presented to our emergency department with redness, swelling in the left eye, and diminished bilateral vision. Fundus examination of the left eye was obscured, while that of the right eye was consistent with subretinal abscess. Therefore, endogenous endophthalmitis was suspected. Imaging revealed two ring-enhancing lesions in the brain, and multiple bilateral small cystic and cavitary lung lesions. Unfortunately, the left eye eventually eviscerated due to the rapid progression of the disease. Cultures from the left eye were positive for Nocardia farcinica. The patient was started on imipenem, trimethoprim/sulfamethoxazole, and amikacin based on culture sensitivity. The patient’s hospitalization course was complicated by his aggressive and advanced condition, which led to his death.

Conclusions

Although the patient’s condition initially improved with the recommended antibiotic regimens, it led to death owing to the patient’s advanced condition. Early detection of nocardial infection in patients with typical or atypical immunosuppressive conditions may improve overall mortality and morbidity. Liver cirrhosis disrupts cell-mediated immunity and may increase the risk of Nocardia infection.

Peer Review reports

Background

Nocardia are Gram-positive aerobic filamentous bacteria that can cause localized (such as pulmonary and primary cutaneous nocardiosis) or disseminated infections. Nocardiosis is uncommon, and an established bacterial infection usually affects immunocompromised patients with cell-mediated abnormalities; however, one-third of patients are immunocompetent [1, 2].

Between 1995 and 2004, 765 Nocardia cases were submitted to the Centers for Disease Control and Prevention (CDC): 28% N. nova complex, 14% N. brasiliensis, 14% N. farcinica, and 13% N. cyriacigeorgica [3].

Despite treatment, nocardiosis was reported to have a high morbidity, and 23.1% of patients had a chronic disease that could not be cured with a high risk of recurrence. Many of these patients developed complications such as scarring, impaired vision, limp amputation, and residual neurological impairment. Regarding mortality, 5.7% of patients died because of complications of the disease [4].

Major risk factors for nocardial infection include typical immunosuppressive conditions, such as cancer, bone marrow or solid organ transplantation, high doses of corticosteroids, and HIV/AIDS. Other atypical conditions include diabetes, connective tissue diseases, alcoholism, and pulmonary alveolar proteinosis [5].

Immunocompromising entities such as autoimmune diseases,and lymphopenia subjects patients to a higher risk of developing disseminated nocardiosis. Soueges et al. found that patient who were infected with Nocardia farcinica were at a higher risk of dissemination [6].

The pace and course of the disease are primarily related to the patient’s immune status. In immunocompetent patients, the disease usually has a chronic course and is likely to be localized to a single area or organ. Hematogenous dissemination is more common in immunocompromised hosts and usually involves the central nervous system and skin [2].

To date, limited data have documented the relationship between nocardiosis and alcoholic liver disease. In this report, we present a case of disseminated nocardia with endogenous endophthalmitis; two ring-enhancing lesions in the brain; and multiple bilateral small, cystic, and cavitary lung lesions in a patient with a medical history of alcoholic liver cirrhosis.

Case presentation

The patient was a 47-year-old man with a history of heavy alcohol intake over the past 4 years (3–4 drinks per day), which was complicated by alcoholic liver cirrhosis (Child–Pugh C/MELD 22), portal hypertension, and esophageal varices grade 2. He presented to our emergency department with redness and swelling in the left eye for 2 months and bilateral diminished vision, mainly in the left eye, over the previous month. The patient had no history of ocular trauma. The associated symptoms included mild right upper quadrant pain, jaundice, unintentional weight loss (approximately 22 kg in the past 3 months), pruritus, and dark-colored urine. Ophthalmic examination done upon presentation is shown in (Table 1).

Table 1 Ophthalmic examination upon presentation

The initial blood analysis was as follows: complete blood count: white blood cells: 10.3 × 103/µL (normal range 4.5 to 11.0 × 106/μL), red blood cells: 3.5 × 106/μL (normal range 4.7 to 6.1 × 106/μL), hemoglobin: 11.2 g/ldl (normal range 13.2 to 16.6 g/dl), platelets: 225 × 103/µL (normal range 150 to 400 × 103/µL); creatinine: 64 µmol/L (normal range 53 to 97.2 µmol/L), serum sodium: 131 mmol/L (normal range 136 and 145 mmol/L), serum potassium: 4.4 mmol/L (normal range 3.6 to 5.2 mmol/L), serum magnesium: 0.74 mmol/L (normal range 0.85 to 1.10 mmol/L), corrected calcium: 2.2 mmol/L (normal range 2.2 to 2.7 mmol/L), Erythrocyte sedimentation rate: 95 mm/hr (normal range 0 to 15 mm/hr); C-reactive protein level: 92 mg/L (normal range < 3 mg/L); total bilirubin: 132 µmol/L (normal range 1.71 to 20.5 µmol/L); alkaline phosphatase: 151 U/L (normal range 44 to 147 U/L); alanine aminotransferase: 33 U/L (normal range 4 to 36 U/L); albumin: 28.7 g/L (normal range 34 to 54 g/L); and lactic acid: 1.8 mmol/L (normal range 0.5 to 2.2 mmol/L).

Computed tomography (CT) of the brain and orbits revealed two ring-enhancing lesions in the left frontal lobe along with orbital findings suggestive of left orbital endophthalmitis (Fig. 1). Contrast-enhanced magnetic resonance imaging was performed to confirm the diagnosis of supra- and infratentorial brain abscesses and left eye endophthalmitis with a subretinal abscess (Fig. 2).

Fig. 1
figure 1

Left image: Axial contrast-enhanced CT scan of the orbits showing generalized scleral thickness of the left eye with heterogeneous increase in density of the vitreous content. Also seen is soft tissue swelling, orbital proptosis, peri- and post-septal orbital fat stranding plus thickening, and enhancement of the globe wall. Findings that are suggestive of endophthalmitis and subretinal abscess. Enlargement of the lacrimal gland is also noted. Right image: Axial section of a contrast-enhanced CT of the brain shows a ring- enhancing lesion in the left frontal lobe measuring 0.9 cm with surrounding vasogenic edema. Findings consistent with intraparenchymal abscess

Fig. 2
figure 2

Contrast-enhanced T1-weighted images. Multiple supra- and infratentorial rim-enhancing lesions. Also noted surrounding vasogenic edema. Findings that are consistent with abscesses. Images on the right show enhancement of the left globe and surrounding soft tissue. Relatively hyperintense subretinal fluid is noted. Findings that are consistent with left eye endophthalmitis and subretinal abscess. The right orbit shows enhancement of the extra-conal soft tissue suggesting involvement

Magnetic resonance cholangiopancreatography was performed to rule out malignancy and hepatic lesions; however, it only showed a cirrhotic liver with portal hypertension without any focal lesions. However, an incidental finding of bilateral lower-lobe pulmonary nodules was noted, for which a dedicated chest CT was planned.

High-resolution chest CT revealed multiple small bilateral cystic and cavitary lung lesions (Fig. 3).

Fig. 3
figure 3

Axial sections of a contrast-enhanced CT scan of the chest show multiple bilateral cystic and cavitary lung lesions, predominantly involving the lower lobes. A cavitary nodule is seen in the superior segment of the left lower lobe showing thickened wall (upper left image)

The patient underwent further investigations, including blood culture, bronchoalveolar lavage culture, AFB of three samples from saliva, QuantiFERON TB gold test, HIV tests, and syphilis serology. However, all tests had negative results.

An ophthalmic examination shown in (Table 1) revealed a subretinal abscess in the right eye. The patient was initially suspected to have endogenous endophthalmitis and was started on intravitreal vancomycin, ceftazidime, and voriconazole. A few days later, the patient’s left eye failed to improve, and as a result, evisceration of the left eye was decided.

Microbiological studies were performed on the left eye specimen; Ziehl–Neelsen (ZN) staining was negative; however, the modified ZN stain was positive. Partial acid-fast bacteria (AFB) stained positive.

Culture of the left eye swab done in Blood agar and MacConkey agar confirmed the diagnosis of Nocardia farcinica infection. Identification was performed using MALDI-TOF and sensitivity using the manual E-test (Table 2).

Table 2 Patient minimum inhibitory concentration with CLSI M24-A2 reference criteria for sensitivity

Histopathological examination revealed dense histiocytic and neutrophilic infiltrates consistent with an abscess (acute endophthalmitis). Special staining including Grocott’s methenamine silver, and periodic acid-Schiff staining yielded negative results, while Acid-fast bacteria (AFB) satin was partially positive.

When disseminated nocardiosis was confirmed, the patient was started on Nocardia treatment (imipenem 500 mg every 8 h IV, trimethoprim/sulfamethoxazole 255 mg every 6 h, and amikacin 15 mg/kg once daily). Within a few days, the patient’s condition improved with complete resolution of the subretinal abscess in the right eye. Follow-up ophthalmic examination during treatment is shown in (Table 3).

Table 3 Ophthalmic examination during treatment

Follow-up magnetic resonance imaging of the brain also showed interval regression in the size of multiple peripherally located bilateral ring-enhancing lesions. However, CT angiography of the chest, which was performed to rule out pulmonary embolism a month after the previous chest CT, revealed progression of multiple bilateral cavitary lung lesions with the development of pneumomediastinum (Fig. 4).

Fig. 4
figure 4

Axial sections of CT angiography of the pulmonary arteries, performed a month after the previous chest CT (Fig. 3), show progression of bilateral cavitary lung lesions and more evident traction bronchiectasis. It also shows development of bilateral peripheral patchy ground glass opacities and compressive atelectasis. Note is also made of pneumomediastinum

During hospital stay, the patient developed acute pancreatitis and acute kidney injury, which were primarily treated with hydration and pain management.

The patient received imipenem, amikacin, trimethoprim/sulfamethoxazole, and neomycin for 6 weeks. The patient was maintained on ocular prednisolone and cyclopentolate, as recommended by an ophthalmologist.

The patient’s hospital course was complicated by his aggressive and advanced condition. He developed septic shock and died of cardiac arrest in the intensive care unit.

Discussion

In most cases, disseminated nocardiosis is transmitted from the lungs to the central nervous system, skin, and soft tissues. This is usually observed in severely immunocompromised patients (patients with AIDS and transplant recipients) [2].

We performed a literature review by searching the MEDLINE database using keywords, including “nocardia,” “nocardiosis,” “alcohol,” and “cirrhosis,” and we found that this is an extremity rare case of disseminated nocardiosis in a patient with a medical background of alcoholic liver cirrhosis.

Torres et al. and Budzik et al. reviewed 53 and 67 cases of Nocardia farcinica, respectively. According to Torres et al., 85% of patients have predisposing factors, and Budzik et al. further investigated these factors. Most patients (61.2%) were immunosuppressed (on chemotherapy or steroids), 17% were solid organ transplant recipients, 13% had chronic obstructive pulmonary disease, 9% had diabetes mellitus, 7.5% were infected with human immunodeficiency virus, another 7.5% had solid neoplasms, and the last 3% had alcoholism [7, 8]. Budzik et al. reviewed 3 patients who were alcoholics that were infected with N. farcinica. Two out of the three patients had another underlying immunosuppressive condition, including renal transplant and diabetes. The third patient was exclusively alcoholic who had an infection involving the CNS, spine, and the psoas muscle [8].

(Table 4) shows the percentage of organ involvement in N. farcinica infection in both studies, where the lung was the most affected organ in both sets of patients, and the eye was infected in only two out of both sets of patients. A comparison of the antibiotic susceptibility of N. farcinica isolated in the cases reviewed by Torres et al. and those isolated in our case demonstrates that most patients were sensitive to trimethoprim-sulfamethoxazole, amikacin, and imipenem [7, 8].

Table 4 Organ involvement in N. farcinica infection

The recommendation is for immunocompetent patients infected with N. farcinica who are susceptible to trimethoprim-sulfamethoxazole, moxifloxacin, amikacin, minocycline, linezolid, ciprofloxacin, and imipenem-cilastatin to be treated for at least 6 months, and the period could increase to at least 12 months if the central nervous system is involved [9,10,11,12]. In our case, the patient was started on imipenem, trimethoprim/sulfamethoxazole, and amikacin, and within a few days, the patient’s condition remarkably improved with complete resolution of the subretinal abscess in the right eye. However, owing to the patient’s advanced and aggressive disease, the he developed septic shock and died in the intensive care unit.

Immunocompromised patients with nocardial infections often exhibit cell-mediated abnormalities [13, 14].

Liver cirrhosis is an atypical immunosuppressive condition associated with immune dysfunction regardless of the cause. This leads to alterations in the hemostatic role of the liver and disrupts the innate and acquired immunity by causing defects in both local and systemic immunity leading to a high mortality rate (30%) and an increase in systemic inflammation and immunodeficiency [15].

Conclusion

Although the patient’s condition initially improved with imipenem, trimethoprim/sulfamethoxazole, and amikacin, the patient’s hospitalization course was complicated and led to death. Early detection of nocardial infection in patients with typical or atypical immunosuppressive conditions may improve overall mortality and morbidity.

Availability of data and materials

The datasets used and/or analysed during the current study available from the corresponding author on reasonable request.

References

  1. Brown-Elliott BA, Brown JM, Conville PS, Wallace RJ. Clinical microbiology reviews. Clin Microbiol Rev. 2006;19(2):259–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Ambrosioni J, Lew D, Garbino J. Nocardiosis: updated clinical review and experience at a tertiary center. Infection. 2010;38(2):89–97.

    Article  CAS  PubMed  Google Scholar 

  3. Uhde KB, Pathak S, McCullum I Jr, Jannat-Khah DP, Shadomy SV, Dykewicz CA, Clark TA, Smith TL, Brown JM. Antimicrobial-resistant nocardia isolates, United States, 1995–2004. Clin Infect Dis. 2010;51(12):1445–8. https://doi.org/10.1086/657399. Epub 2010 Nov 8 PMID: 21058914.

    Article  PubMed  Google Scholar 

  4. Martínez-Barricarte R. Isolated nocardiosis, an unrecognized primary immunodeficiency? Front Immunol. 2020;20(11):590239.

    Article  Google Scholar 

  5. Centers for Disease Control and Prevention. Nocardiosis: risk of infection. 2022. https://www.cdc.gov/nocardiosis/infection/index.html. Accessed 11 Oct 2022.

  6. Soueges S, Bouiller K, Botelho-Nevers E, Gagneux-Brunon A, Chirouze C, Rodriguez-Nava V, Dumitrescu O, Triffault-Fillit C, Conrad A, Lebeaux D, Hodille E. Prognosis and factors associated with disseminated nocardiosis: a ten-year multicenter study. J Infect. 2022;85(2):130–6.

    Article  CAS  PubMed  Google Scholar 

  7. Torres OH, Domingo P, Pericas R, Boiron P, Montiel JA, Vázquez G. Infection caused by Nocardia farcinica: case report and review. Eur J Clin Microbiol Infect Dis. 2000;19(3):205–12. https://doi.org/10.1007/s100960050460.

    Article  CAS  PubMed  Google Scholar 

  8. Budzik JM, Hosseini M, Mackinnon AC Jr, Taxy JB. Disseminated Nocardia farcinica: literature review and fatal outcome in an immunocompetent patient. Surg Infect (Larchmt). 2012;13(3):163–70. https://doi.org/10.1089/sur.2011.012. Epub 2012 May 21 PMCID: PMC3375863.

    Article  PubMed  Google Scholar 

  9. Mamelak AN, Obana WG, Flaherty JF, Rosenblum ML. Nocardial brain abscess: treatment strategies and factors influencing outcome. Neurosurgery. 1994;35:622–31.

    Article  CAS  PubMed  Google Scholar 

  10. Hansen G, Swanzy S, Gupta R, Cookson B, Limaye AP. In vitro activity of fluoroquinolones against clinical isolates of Nocardia identified by partial 16S rRNA sequencing. Eur J Clin Microbiol Infect Dis. 2008;27(2):115–20.

    Article  CAS  PubMed  Google Scholar 

  11. Jodlowski TZ, Melnychuk I, Conry J. Linezolid for the treatment of Nocardia spp. infections. Ann Pharmacother. 2007;41:1694–9.

    Article  CAS  PubMed  Google Scholar 

  12. Minero MV, Marin M, Cercenado E, Rabadán PM, Bouza E, Muñoz P. Nocardiosis at the turn of the century. Medicine. 2009;88:250–61.

    Article  PubMed  Google Scholar 

  13. Lederman ER, Crum NF. A case series and focused review of nocardiosis: clinical and microbiologic aspects. Medicine (Baltimore). 2004;83(5):300–13. https://doi.org/10.1097/01.md.0000141100.30871.39. PMID: 15342974.

    Article  PubMed  Google Scholar 

  14. Palmer DL, Harvey RL, Wheeler JK. Diagnostic and therapeutic considerations in Nocardia asteroides infection. Medicine. 1974;53(5):391–401.

    Article  CAS  PubMed  Google Scholar 

  15. Noor MT, Manoria P. Immune dysfunction in cirrhosis. J Clin Transl Hepatol. 2017;5(1):50–8. https://doi.org/10.14218/JCTH.2016.00056. Epub 2017 Mar 10. PMID: 28507927; PMCID: PMC5411357.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

None.

Funding

This case report is not funded.

Author information

Authors and Affiliations

Authors

Contributions

Rewaa Alqurashi wrote and reviewed the manuscript Husam Alobida reviewed the manuscript Abdullah Albathi prepared figures, wrote captions, and reviewed the manuscript Moneera Aldraihem wrote the discussion.

Corresponding author

Correspondence to Rewaa Alqurashi.

Ethics declarations

Ethics approval and consent to participate

It was taken from the hospital’s Institutional Review Board.

Consent for publication

Written informed consent was obtained from patient’s brother for publication of this case report.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alqurashi, R., Alobida, H., Albathi, A. et al. Disseminated nocardiosis in a patient with alcoholic liver cirrhosis: a case report. BMC Infect Dis 23, 445 (2023). https://doi.org/10.1186/s12879-023-08421-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12879-023-08421-7

Keywords